Overview

Placebo Controlled Trial of Bosentan in Scleroderma Patients

Status:
Terminated
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the drug Bosentan improves exercise tolerance in scleroderma patients.
Phase:
Phase 2
Details
Lead Sponsor:
Georgetown University
Collaborator:
Actelion
Treatments:
Bosentan